President and CEO of Praxis Precision Medicines (PRAX) Marcio Souza joins The Watch List one year following the company's public listing. Souza talks about how the biopharmaceutical company is attempting to combat the mental health crisis overtaking the U.S. Praxis develops therapies for central nervous system disorders characterized by neuronal imbalance like major depressive disorder and posttraumatic stress disorder.
The Watch List
12 Oct 2021
SHARE
Morning Trade Live
12 Aug 2022
The Watch List
06 Sep 2022
The Watch List
03 Aug 2022
The Watch List
29 Jul 2022
Morning Trade Live
15 Aug 2022
Morning Trade Live
06 Sep 2022